Development

, Volume 49, Issue 4, pp 54–59 | Cite as

Nanotechnology in Medicine: Implications of converging technologies on humanity

  • Debra Bennett-Woods
Thematic Section: Nanotechnology, Ethics and Development
First Online:

Abstract

Nanotechnology holds great potential as an enabler of a wide range of biotechnologies that will change the face of medicine and may eventually alter the very definition of human health. Deb Bennett-Woods argues that these changes will also pose unprecedented challenges regarding access to health-related technologies, the meaning of consent, and the nature of human identity.

Keywords

converging technologies biotechnology NBIC global health nanomedicine ethics 
This is a preview of subscription content, log in to check access.

References

  1. Altmann, Jürgen (2005) ‘Limiting Military Uses of Nanotechnology and Converging Technologies’, Marburg, Germany, 13–15 January 2005.Google Scholar
  2. Bennett-Woods, Debra (2006) ‘A Framework for the Pragmatic Integration of the Ethical Considerations of Societal Impacts Into Funding Decisions for Emerging Technologies’, Journal of Nanotechnology Law and Business (in press).Google Scholar
  3. Berube, David M. (2006) Nano-hype: The truth behind the technology buzz, New York: Prometheus Books.Google Scholar
  4. Campo, Aránzazu and Ian J. Bruce (2005) ‘Diagnostics and High Throughput Screening’, in Neelina H. Malsch (ed.) Biomedical Nanotechnology, Boca Raton: Taylor & Francis.Google Scholar
  5. Daar, Abdallah S., Halla Thorsteinsdóttir, Douglas K. Martin, Alyna C. Smith, Shauna Nast and Peter A. Singer (2002) ‘Top Ten Biotechnologies For Improving Health in Developing Countries’, Nature Genetics 32: 229–232.CrossRefGoogle Scholar
  6. Ferrari, Mauro and Gregory Downing (2005) ‘Medical Nanotechnology: Shortening clinical trials and regulatory pathways?’ Biodrugs 19 (4): 203–210.CrossRefGoogle Scholar
  7. Fukuyama, Francis (2002) Our Posthuman Future: Consequences of the biotechnology revolution, New York: Picador.Google Scholar
  8. Hughes, James (2004) Citizen Cyborg: Why democratic societies must respond to the redesigned human of the future, New York: Westview Press.Google Scholar
  9. Ivnitski, Dmitri, Daniel J. O'Neil, Anothony Gattuso, Roger Schlicht, Michael Calidonna and Rodney Fisher (2003) ‘Nucleic Acid Approaches for Detection and Identification of Biological Warfare and Infectious Disease Agents’, Biotechniques 35 (4): 862–869.Google Scholar
  10. Kayser, O., A. Lemke and N. Hernández-Trejo (2005) ‘The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems’, Current Pharmaceutical Biotechnology 6: 3–5.CrossRefGoogle Scholar
  11. Kubik, T., K. Bogunia-Kubik and M. Sugisaka (2005) ‘Nanotechnology on Duty in Medical Applications’, Current Pharmaceutical Biotechnology 6: 17–33.CrossRefGoogle Scholar
  12. Lindpainter, Klaus (2003) ‘Pharmacogenetics and the Future of Medical Practice’, Journal of Molecular Medicine 81: 141–153.CrossRefGoogle Scholar
  13. Mazzola, Laura (2003) ‘Commercializing Nanotechnology’, Nature Biotechnology 21 (10): 1137–1143.CrossRefGoogle Scholar
  14. Meridian Institute (2005) ‘Nanotechnology and the Poor: Opportunities and Risks’, published report, Meridian Institute.Google Scholar
  15. Naam, Ramez (2005) More Than Human: Embracing the promise of biological enhancement, New York: Broadway Books.Google Scholar
  16. Nanoforum.org (2003) Nanotechnology and its Implications for the Health of the EU Citizen.Google Scholar
  17. National Science Foundation (March 2001) ‘Societal Implications of Nanoscience and Nanotechnology’, publishes report, Arlington: National Science Foundation.Google Scholar
  18. Roco, Mihail C. (2003) ‘Nanotechnology: Convergence with modern biology and medicine’, Current Opinion in Biotechnology 14: 337–346.CrossRefGoogle Scholar
  19. Schuler, Emmanuelle (2005) ‘Potential Risks and Remedies’, in Neelina H. Malsch (ed.) Biomedical Nanotechnology, Boca Raton: Taylor & Francis.Google Scholar
  20. Shipbaugh, Calvin, Philip Antón, Gabrielle Bloom, Brian Jackson and Richard Silberglitt (2005) ‘Nano-Enabled Components and Systems for Biodefense’, in Neelina H. Malsch (ed.) Biomedical Nanotechnology, Boca Raton: Taylor & Francis.Google Scholar
  21. Stock, Gregory (2002) Redesigning Humans: Our inevitable genetic future, Great Britain: Profile Press.Google Scholar
  22. Sweet, Leonard and Bradford Strohm (2006) ‘Nanotechnology: Life-cycle risk management’, Human and Ecological Risk Assessment 12 (3): 528–551.CrossRefGoogle Scholar
  23. Van den Bueken, X., Frank Walboomers and John A. Jansen (2005) ‘Implants and Prostheses’, in Neelina H. Malsch (ed.) Biomedical Nanotechnology, Boca Raton: Taylor & Francis.Google Scholar
  24. Weston, Andrea D. and Leroy Hood (2004) ‘Systems Biology, Proteomics, and the Future of Health Care: Toward predictive, preventative, and personalized medicine’, Journal of Proteome Research 3: 179–196.CrossRefGoogle Scholar
  25. World Health Organization (2002) ‘The World Health Report 2002: Reducing risks, promoting healthy life’, published report, Geneva: World Health Organization.Google Scholar

Copyright information

© Society for International Development 2006

Authors and Affiliations

  • Debra Bennett-Woods

There are no affiliations available

Personalised recommendations